Back to ENGNW

FCPM III SERVICES B.V. → ENGNW

FCPM III SERVICES B.V. ENGNW Position History

enGene Therapeutics Inc. • Healthcare

Quarters held
16
Latest value
$95K
Q3 2026
Peak value
$60.8M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$60.8M
Q4 2025$26.1M
Q4 2025$7.1M
Q4 2025$1.4M
Q1 2026$45.9M
Q1 2026$19.7M
Q1 2026$6.1M
Q1 2026$1.2M
Q2 2026$11.7M
Q2 2026$5M
Q2 2026$697K
Q2 2026$138K
Q3 2026$13.5M
Q3 2026$5.8M
Q3 2026$481K
Q3 2026$95K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$95K475.1K——
Q3 2026$481K2.40M——
Q3 2026$5.8M2.89M——
Q3 2026$13.5M6.74M——
Q2 2026$138K475.1K——
Q2 2026$697K2.40M——
Q2 2026$5M2.89M——
Q2 2026$11.7M6.74M——
Q1 2026$1.2M475.1K——
Q1 2026$6.1M2.40M——
Q1 2026$19.7M2.89M——
Q1 2026$45.9M6.74M——
Q4 2025$1.4M475.1K——
Q4 2025$7.1M2.40M——
Q4 2025$26.1M2.89M——
Q4 2025$60.8M6.74M——

Other funds holding ENGNW

Other FCPM III SERVICES B.V. positions

NAMSW

NEWAMSTERDAM PHARMA COMPANY

$163.1M
NAMSW

NEWAMSTERDAM PHARMA COMPANY

$159.6M
NAMSW

NEWAMSTERDAM PHARMA COMPANY

$157.5M
NAMSW

NEWAMSTERDAM PHARMA COMPANY

$148.8M
NAMSW

NEWAMSTERDAM PHARMA COMPANY

$145.7M
NAMSW

NEWAMSTERDAM PHARMA COMPANY

$130.2M
MPLT

MAPLIGHT THERAPEUTICS INC

$115.6M
NAMSW

NEWAMSTERDAM PHARMA COMPANY

$113M